tirzepatide 2024 Weight-loss drug drives Eli Lilly to raise sales forecast by $2 billion Weight-loss drug tirzepatide may lower

Also read: Liposomal Glutathione: The Glass Skin Hack vs

They do not account for patients who left the platform without completing a check-in, which per the company's own disclosure creates inherent selection effects - people who had positive experiences are more likely to complete surveys than people who did not notice a difference

And on the whole it's failed - more than half the planet is projected to be overweight or obese by 2035, driving up cases of type 2 diabetes, heart disease and some cancers

Primary Handling Editors: Revati Dewal, Christoph Schmitt and Isabella Samuelson, in collaboration with the Nature Metabolism team